ANDREW WILLIAMS: Open Payments
NPI 1346627551 · BEAVERTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 15 payments from 6 companies in 2025. Trend: 2023 $75,932 · 2024 $6,568 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $349 |
| Neuronetics, Inc. | 4 | $285 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 1 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
Products named: SPRAVATO, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, COBENFY, TRINTELLIX, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across OR — which companies pay providers there.
